• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ariatti joins Toshiba as marketing VP

Article

Toshiba America Medical Systems has named John Ariatti as vicepresident of marketing to replace Ravi Sharma, who left the Tustin,CA, firm in July (SCAN 8/2/95). Ariatti is a medical imaging veteranwho previously was director of sales and marketing at

Toshiba America Medical Systems has named John Ariatti as vicepresident of marketing to replace Ravi Sharma, who left the Tustin,CA, firm in July (SCAN 8/2/95). Ariatti is a medical imaging veteranwho previously was director of sales and marketing at Otsuka Electronicsand then at Elscint after that company acquired Otsuka last year.

Ariatti rejoins Toshiba after a stint with the vendor beginningin 1989, when he served as director of the CT business unit andlater as director of MRI marketing. He has also worked with PhilipsMedical Systems.

In his new position, Ariatti oversees marketing for Toshiba'sCT, MRI, nuclear medicine, and vascular and general x-ray products,as well as corporate marketing and marketing communications.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.